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Case Report
Prostate Cancer Metastasis to the Stomach
Kyoung Pyo Hong, Seong Ju Lee, Geun Sik Hong, Hana Yoon, Bong Suk Shim
Department of Urology, Ewha Womans University School of Medicine, Seoul, Korea
Prostate cancer commonly manifests with bony metastases. Visceral metastasis can 
also occur in the lungs and liver. However, stomach metastasis related to prostate cancer 
is rare. Here, we report a case of prostate cancer metastatic to the stomach. A 66-year-old 
male was diagnosed with prostate adenocarcinoma. He was noted as having abdominal 
discomfort, nausea, and vomiting 18 months after the diagnosis. A histopathologic ex-
amination and an esophagogastroduodenoscopic gastric biopsy revealed stomach-meta-
static adenocarcinoma. He was also noted as having cerebellar metastatic lesions, which 
were identified by using a brain magnetic resonance imaging (MRI) scan. The patient 
died of cardiovascular complications 5 months after the diagnosis of stomach metastasis.
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Prostate cancer commonly metastasizes to the bones and 
lymph nodes, but seldom to the lungs or liver. Prostate can-
cer metastatic to the stomach is also rare. A search of pub-
lished reports revealed only three cases [1-3]. Here, we 
present the case of a 66-year-old male with prostate cancer 
metastatic to the stomach. 
CASE REPORT
A 66-year-old male visited our hospital with painless gross 
hematuria with blood clots for the previous 1 month. A cys-
toscopic examination revealed a huge bladder neck mass 
and a transurethral resection of the bladder tumor (TUR- 
BT) was performed. The histology showed an adenocarcinoma 
of the prostate, with a Gleason score of 9 (5＋4). The pa-
tient’s initial prostate-specific antigen (PSA) was 2.0 ng/ml. 
Magnetic resonance imaging (MRI), computed tomography 
(CT), and bone scans did not show metastatic lesions. The 
clinical stage of prostate cancer was pT4a cN0 cM0 at the 
time of diagnosis. 
　The patient underwent a course of prostatic intensity- 
modulated radiation therapy (IMRT) to 7,800 cGy in 39 frac-
tions 1 month after the diagnosis. An adjuvant treatment 
of total androgen blockade (TAB) with a luteinizing hormone- 
releasing hormone (LHRH) agonist and an anti-androgen 
was administered 3 months after the diagnosis. The pa-
tient’s PSA level rose to 2.5 ng/ml 7 months after radiation 
treatment and then rose to 17.9 ng/ml after 9 months. He 
did not respond to the prostatic IMRT with adjuvant hormo-
nal therapy. A follow-up bone scan showed multiple bone 
metastases in the thoracic spine, both iliac bones, and the 
left femur 9 months after radiation treatment. The patient 
refused chemotherapy with docetaxel. Therefore, we main-
tained TAB treatment.
　The patient complained of abdominal discomfort, nau-
sea, and vomiting 18 months after the diagnosis. Multiple 
small, elevated mucosal ulcerations on the anterior wall of 
the gastric antrum were observed by use of esophagogas-
troduodenoscopy (Fig. 1). An esophagogastroduodenosco-
pic biopsy of the gastric antrum showed an undifferen-
tiated carcinoma. The histopathology of the gastric biopsy 
showed infiltration of neoplastic cells with marked atypical 
nucleoli and abundant eosinophilic cytoplasm (Fig. 2A). 
The immunohistochemical workup with PSA stain proved 
metastatic prostate adenocarcinoma (Fig. 2B). 
　The patient began chemotherapy with docetaxel 19 months 
after the diagnosis. He was given an intravenous dose of 
120 mg (75 mg/m
2) docetaxel with prednisolone every 3 weeks 
for three cycles. The bone and lymph node disease remained 
stable for several months with an acceptable performance 
status and no significant treatment-induced toxicity.
　The patient complained of facial numbness on the right 
side 21 months after the diagnosis. A MRI brain scan con-
firmed an intracerebral mass measuring 2x1.6 cm in the Korean J Urol 2010;51:431-433
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FIG. 2. Histopathology of the gastric biopsy. (A) Infiltration of neoplastic cells with marked atypical nucleoli and abundant 
eosinophilic cytoplasm (H&E, x100). (B) Positive response of prostate-specific antigen (PSA) stain: the color of the cytoplasm in 
neoplastic cells changed to brown (PSA stain, x200).
FIG. 3. Brain magnetic resonance imaging (MRI) scan showing a
2x1.6 cm mass with an irregular margin and a high signal 
intensity in the base of the right cerebellum (black arrow).
FIG. 1. Esophagogastroduodenoscopy: Multiple small elevated 
mucosal ulcerations on the anterior wall of the gastric antrum 
are shown (black arrow).
right cerebellum (Fig. 3). Whole-brain radiation therapy 
was performed.
　Pulmonary edema was noted and unfortunately the pa-
tient died of cardiac arrest 5 months after the diagnosis of 
stomach metastasis. 
DISCUSSION
Prostate cancer commonly metastasizes to the bones and 
lymph nodes; its spread to the gastrointestinal (GI) tract 
is rare. A search of published reports revealed only three 
cases of prostate cancer metastatic to the stomach [1-3]. 
However, there have been reports of prostate cancer meta-
static to other sites of the GI tract [4-6]. Two postmortem 
studies of between 67 and 347 patients with metastatic 
prostate cancer revealed an incidence of gastric metastasis 
in 1% to 4% of cases [7,8].
　Our patient’s initial PSA was lower than in other cases. 
The initial PSA of the patient in the first case reported by 
Onitilo et al was 1,565 ng/ml [3]. 
　Our patient had hormone-refractory prostate cancer 
with systemic tumor disease involving the lymph nodes 
and bone metastasis. The patient in the first case reported 
by Onitilo et al had indolent disease before presenting with 
gastric metastasis. The patient responded rapidly and dra-
matically to treatment and his GI bleeding and other symp-
toms were resolved [3]. 
　Our patient died of cardiac arrest 23 months after the ini-Korean J Urol 2010;51:431-433
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tial diagnosis of prostate cancer. The patient in the first 
case reported by Onitilo et al died 19 months after the initial 
diagnosis of prostate cancer [3]. Other patients were alive 
when the reports were published [1-3].
　The mechanism of metastasis to the GI tract from prostate 
cancer is unclear. Hematogenous, lymphatic, and direct in-
filtrations are the typical routes of spread [9]. Because the 
prostate is richly supplied with lymphatic channels, most 
GI spread to the abdomen is via the lymphatic route.
　In this and other cases, the most common symptoms asso-
ciated with stomach metastases from prostate cancer were 
nausea and vomiting [1-3]. We emphasize that in patients 
with a history of prostate cancer and new-onset GI manifes-
tations with nausea and vomiting, the elevation of intra-
cranial pressure with brain metastasis and stomach meta-
stasis should be considered in the differential diagnosis. 
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